CE/Events
Prev MonthPrev Month Next MonthNext Month
RXPP 6330/6220: Treatment of Bipolar & Post-Traumatic Stress Disorders | via NMSU
Saturday, October 26, 2024, 9:00 AM to Sunday, October 27, 2024, 6:00 PM CDT
Category: Events

RXPP 6330/6220: Treatment of Bipolar & Post-Traumatic Stress Disorders | via NMSU
(13.5 Hours)
ONLINE

The Iowa Psychological Association is pleased to partner with New Mexico State University's Clinical Psychopharmacology Post- Doctoral Masters Degree Program to offer Continuing Education (CE) training to IPA members.

Topic:
RXPP 6330/6220: Treatment of Bipolar & Post-Traumatic Stress Disorders

Credit Hours: 13.5 CEUs (Provided by NMSU, Sponsored by APA) NMSU is approved by the American Psychological Association to sponsor continuing education for psychologists. NMSU maintains responsibility for the program and its content

Location: Online

Date/Time
October 26 & 27, 2024
9:00am - 6:00pm CST

Instructor:
Leigh Ann Ford, PhD, MSCP

Cost
$300: IPA Member
$200: IPA Lifetime Member
$200: IPA ECP Member
$130: IPA Retired Member
$0: IPA Student Member
$450: Non-Member

About This Workshop

In this RXPP 604 class we begin our study of clinical psychopharmacology through the study of the treatment of bipolar disorder (Day 1) and Post-Traumatic Stress Disorder (Day2). Objectives of this course are to understand the biochemical mechanism(s) underlying the pharmacological efficacy of antimanic and PTSD treatments; the biochemical, physiological and anatomical bases of adverse effects associated with antimanic and PTSD treatments; different classes of antimanic drugs and treatments and drugs used to aid in the treatment of PTSD; typical antipsychotic medications, atypical antipsychotics, electroconvulsive therapy (ECT), lithium (Li+), anticonvulsants,and other treatments for bipolar disorder; symptom modify ingmedications and treatments for PTSD; and to be able to effectively prescribe these medications and manage the medical issues that arise from their use.

Learning Objectives

Participants will be able to:
First Day Objectives:
1. Describe the mechanism of action of five psychotropic medications (e.g. Lithium, Valproate, Lamotrigine, Second Generation Antipsychotics and Benzodiazepines) in treating bipolar disorder.
2. Describe the mechanism of action of the two adjunctive mood stabilizers Gabapentin and Oxcarbazepine.
3. Explain at least two genetic predisposing factors for the development of bipolar disorder.
4. Select the most appropriate psychotropic medications for bipolar disorders considering the effect and the side effect profile of each drug for two patients whose cases will be presented.
5. Accurately evaluate one serum level each for Lithium, Carbamazepine and Depakote to determine the safety of patient’s current regimen of medication.
6. List four factors which contribute to poor response to mood stabilizers in the treatment of bipolar disorder.
7. List three pathological syndromes commonly mistaken for bipolar disorder.
8. Explain the three most important psychotherapeutic goals in assisting patients in managing their bipolar disorder.

Second Day Objectives:
1. Describe at least two neuroanatomical changes that contribute to the development of PTSD.
2. Explain the role of at least four features of the sympathetic nervous system and the three neuroendocrine (hypothalamic-pituitary-adrenal axis; HPA) components in the development and maintenance of the symptoms of PTSD.
3. Distinguish 1 difference between the negative and positive feedback loop of the HPA axis.
4. Explain of the mechanisms of actions of the at least one Alpha and one Beta Antagonist used in treatment of PTSD.
5. Select the most appropriate psychotropic medications for the treatment of PTSD symptoms in two of the presented cases of individuals experiencing PTSD symptoms.
6. Name two classes of drugs that are not recommended in the treatment of PTSD symptoms.
7. List two common co-morbid conditions with PTSD and explain how treatment of the comorbid conditions may complicate the treatment of PTSD symptoms.
8. Develop one sample treatment plan for a patient, presented as a case example that is comprehensive and is based on the evidence that shows components of treatment that are most effective.
9. List two important factors that distinguish PTSD from other anxiety disorders Learning Objectives


Click here to register


Course Materials and Continuing Education

NMSU will email registrants course materials, and a link to join the live training two business days before the training.

Upon completion of the training, NMSU will email registrants the training evaluation. Upon completion of the training evaluation, the NMSU will email the registrant the CE certificate.


Refund and Cancellation Policy

We understand, sometimes things come up!

IPA will offer a full refund to registrants who cancel their registration 7 days prior to an event/course. If a registrant would like to cancel their registration within 7 days of the event, no refund will be offered.


Contact: Suzanne Hull, [email protected]